SCHEDULE Of COMMON STOCK PURCHASE WARRANTS ISSUED AND OUTSTANDING (Details) - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Equity [Abstract] | ||
Warrants Outstanding, Beginning balance | 29,700,000 | 40,764,666 |
Weighted Average Exercise Price, Beginning balance | $ 0.13 | $ 0.13 |
Warrants outstanding, granted | 1,000,000 | 9,400,000 |
Weighted average exercise price, granted | $ 0.10 | $ 0.09 |
Warrants outstanding, expired | (6,730,000) | (20,464,666) |
Weighted average exercise price, expired | $ 0.11 | $ 0.11 |
Warrants Outstanding, Ending balance | 23,970,000 | 29,700,000 |
Weighted Average Exercise Price, Ending balance | $ 0.13 | $ 0.13 |
X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
X | ||||||||||
- Definition Warrants weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|